Explained here why Johnson & Johnson is setting a $2 billion trust

Invezz

Published

Johnson & Johnson (NYSE: JNJ) put its obligations for tens of thousands of cases tying talc-based products to cancer into bankruptcy. The company hopes the action will help push a personal injury claims settlement. Johnson & Johnson corporate partner files for bankruptcy On Thursday, Johnson & Johnson said that a corporate partner with talc-related liabilities […]

Full Article